Jazz Pharmaceuticals plc — Director's Dealing 2018

Jan 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2018-01-16

Reporting Person: Young Matthew P. (EVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-16	Ordinary Shares	S	700	$152.16	Disposed	38959	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Includes 62 ordinary shares acquired on May 31, 2017 and 64 ordinary shares acquired on November 30, 2017 under a Section 423 Employee Stock Purchase Plan.